Global Smart Syringe Market by Manufacturers, Countries, Type and Application, Forecast to 2026

The global smart syringe market was valued at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025, registering a CAGR of 10.3% during the forecast period.

Smart syringes are designed with features to offer protection from needle stick injuries, blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and life-threatening infections. They cater to several applications that include vaccination, drug delivery, and blood specimen collection. Smart syringes are of various types, which include auto disable (AD) syringes, passive safety syringes, and active safety syringes are used depending on the nature of application.

Request a Sample Copy:

Active safety syringes are the most common type of smart syringes used across all healthcare sectors, whereas, auto disable (AD) syringes are the most popular syringes used for vaccination purpose.

The industry is driven by increase in needle stick injuries, high prevalence of blood-borne transmission such as hepatitis B, C, HIV through improper injection practices, growth in adoption of safety syringes, and surge in technological advancements. In addition, the WHO mandate to switch to smart syringes to ensure safe injection practices is a major factor that boosts the growth of the market. However, high cost associated with smart syringes, especially passive safety syringes, low awareness in developing economies, and alternative drug delivery methods are expected to impede the market growth. The global smart syringes market volume is projected to reach 15.8 billion units by 2020 and is anticipated to grow at a CAGR of 8.2 during the forecast period.

The global smart syringe market is segmented based on product type, application, age group, end user, and region. Based on product type, the market is segmented into auto disable (AD) syringes, active safety syringes, and passive safety syringes. Based on application, the market is classified into drug delivery, vaccination, and blood specimen collection. Based on age group, the market is bifurcated into pediatric and adult. Based on end user, the market is categorized into hospitals and HMOs, diabetic patients, family practices, psychiatrics, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Ask for a Discount:

The top players have been profiled in this research study such as Welltok, Inc., Intel Corporation, Nvidia Corporation, Google Inc., IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, Berg Health. The other players of the smart syringe market include (companies not profiled in the report) L.O.M. Medical International, Techcon, Tecan Trading AG, Meissner Filtration Products, Inc., ARxIUM,  and Parker Hannifin Corporation.

Related Report:

Global IV Flush Syringe Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

This report focuses on the IV Flush Syringe in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

In the last several years, global market of IV Flush Syringe developed rapidly, with an average growth rate of 6.18%. In 2017, global revenue of IV Flush Syringe is nearly 274 M USD; the actual production is about 426 million units.

The worldwide market for IV Flush Syringe is expected to grow at a CAGR of roughly 7.3% over the next five years, will reach 420 million US$ in 2023, from 270 million US$ in 2017, according to a new study.

Read More:

 About Us:

 Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.

We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities.  Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us

Global Head Quarters

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

+1 (800) 910-6452

[email protected]

Posted by on Friday October 12 2018, 6:23 AM EST. All trademarks acknowledged. Filed under Featured Press Release, Life Sciences, Medical Devices. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Latest News

Log in